Medly Therapeutics
PrivateLast Round
Grant
Feb 18, 2025
Total Funding Raised
$1.35M
Company Overview
Medly Therapeutics is a digital health company that provides an AI-powered, clinically validated platform for the remote management of chronic conditions, including heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Patient Engagement, Telemedicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medly Therapeutics Comparables
Compare Medly Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeamlessMD | 76% | |
| Veta Health | 76% | |
| CareSimple | 73% |
Medly Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 18, 2025 |
Medly Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2025
$1.35M grant from Canadian Institutes of Health Research
Medly Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medly Therapeutics's valuation, stock price, and market status.
Is Medly Therapeutics a public or private company?
Medly Therapeutics is a private company.
What is the current stock price of Medly Therapeutics?
Medly Therapeutics is a private company with no public stock price. Caplight tracks Medly Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Medly Therapeutics worth (valuation)?
Valuation information for Medly Therapeutics is not publicly available.
Can I buy Medly Therapeutics stock?
Medly Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Medly Therapeutics's last funding round?
Medly Therapeutics's most recent funding round was Grant on February 18, 2025.
Who are the main investors in Medly Therapeutics?
Key investors in Medly Therapeutics include Canadian Institutes of Health Research.
Will Medly Therapeutics IPO soon?
No public IPO plans have been announced for Medly Therapeutics.
How can I track Medly Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medly Therapeutics's secondary market activity and sign up for updates.